According to recent research published in 2023, Gastroparesis is relatively uncommon in the United States, with approximately 9.6 cases per 100,000 person-years for men and 37.8 cases per 100,000 person-years for women
Understanding your peptide genetic profile alongside your cardiovascular biomarkers can support a more personalized discussion with your provider about GLP-1 eligibility, expected benefits, monitoring frequency, and whether compounded GLP-1 options (semaglutide or tirzepatide) align with your individual health trajectory
The software infrastructure supporting this process ensures data is encrypted, appointment scheduling is seamless, and user feedback can be tracked longitudinally - a key difference from static supplement routines or manual email-driven services
And it's not just on peptides
Because of this, the effects of glutathione depend on ongoing body processes